Jefferies Group LLC Natera, Inc. Transaction History

Jefferies Group LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$28.13 - $44.54 $1.34 Million - $2.13 Million	-47,712 Closed	0 $0
Q1 2022 Sep 21, 2023	BUY	$30.32 - $91.33 $683,716 - $2.06 Million	22,550 Added 153.4%	37,250 $1.52 Million
Q1 2022 May 16, 2022	BUY	$30.32 - $91.33 $1.45 Million - $4.36 Million	47,712 New	47,712 $1.54 Million
Q2 2021 Aug 16, 2021	SELL	$86.05 - $119.72 $1.26 Million - $1.76 Million	-14,700 Closed	0 $0
Q1 2021 Sep 21, 2023	BUY	$91.47 - $124.36 $1.34 Million - $1.83 Million	14,700 New	14,700 $1.49 Million
Q1 2021 May 14, 2021	BUY	$91.47 - $124.36 $1.34 Million - $1.83 Million	14,700 New	14,700 $1.49 Million
Q1 2018 May 15, 2018	SELL	$9.0 - $11.95 $129,960 - $172,558	-14,440 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$8.99 - $14.31 $129,815 - $206,636	14,440	14,440 $130,000

526

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.2B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.